SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

AQST - Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film

AQST

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.